Connectome Health develops non-invasive brain monitoring solutions based on functional near-infrared spectroscopy (fNIRS) to assess cognitive and brain health metrics. The company’s platform delivers rapid brain scans that measure hemodynamic activity associated with cortical function. Its system combines wearable fNIRS hardware with software designed to generate interpretable insights from brain data. Connectome Health positions its technology within brain health monitoring and applied neuroscience contexts.

The technology measures changes in oxygenated and deoxygenated hemoglobin in cortical regions to infer neural activity related to cognitive processes. AI-driven analytics are applied to these signals to generate metrics associated with focus, memory, stress resilience, and other functional states. Scans are designed to be quick and repeatable, enabling longitudinal tracking without the need for invasive procedures or large imaging systems. This approach emphasizes accessibility and real-time feedback rather than laboratory-grade imaging.

Connectome Health targets applications in cognitive assessment, performance monitoring, and longevity-oriented brain health tracking. The platform is positioned outside traditional diagnostic pathways, providing informational and trend-based insights rather than clinical diagnoses. Its focus reflects growing interest in scalable, non-invasive tools for monitoring brain function over time in everyday and preventive health contexts.